MedTrace Logo

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

NCT05866887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-06-06

Study results available
· View outcomes & findings →

Summary

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers.

The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

Conditions

Interventions

BEHAVIORAL

Sleep ALL Night

Sleep intervention program comprised of a sleep action plan tool and interactive psychoeducation website.

Sponsors & Collaborators

Principal Investigators

  • Eric Zhou, PhD · Dana-Farber Cancer Institute

  • Kira Bona, MD · Dana-Farber Cancer Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-26
Primary Completion
2024-06-05
Completion
2024-06-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05866887 on ClinicalTrials.gov